FDA Inspection 1141253 — Charles A. Leath III, M.D.
The FDA completed an inspection of Charles A. Leath III, M.D. on April 22, 2021 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 22, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham, AL (United States)
Additional Details
Clinical Investigator (CI)